NCT01565447View on ClinicalTrials.gov

Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study

CompletedOBSERVATIONAL
Enrollment

109

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 20, 2023

Study Completion Date

March 20, 2023

Conditions
Acute Lymphoblastic LeukemiaChildhood Lymphoblastic Lymphoma
Trial Locations (1)

97239

Doernbecher Children Hospital, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT01565447 - Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study | Biotech Hunter | Biotech Hunter